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Abstract
Background: An important role for synovial pathology in the initiation and progression of knee osteoarthritis has
been emphasised recently. This study aimed to examine whether ultrasonography-detected synovial changes associate
with knee pain (KP) in a community population.
Methods: A case–control study was conducted to compare people with early KP (n = 298), established KP (n = 100) or
no KP (n = 94) at baseline. Multinomial logistic regression was used to estimate the odds ratio (OR) and 95% confidence
interval (CI) between groups adjusted for radiographic osteoarthritis (ROA) severity and other confounding factors. After
1 year, 255 participants with early and established KP completed the follow-up questionnaire for changes in KP. Logistic
regression with adjustment was used to determine predictors of KP worsening.
Results: At baseline, effusion was associated with early KP (OR 2.64, 95% CI 1.57–4.45) and established KP (OR 5.07,
95% CI 2.74–9.38). Synovial hypertrophy was also associated with early KP (OR 5.43, 95% CI 2.12–13.92) and established
KP (OR 13.27, 95% CI 4.97–35.43). The association with effusion diminished when adjusted for ROA. Power Doppler
signal was uncommon (early KP 3%, established KP 2%, controls 0%). Baseline effusion predicted worsening of KP at
1 year (OR 1.95, 95% CI 1.05–3.64). However, after adjusting for ROA, the prediction was insignificant (adjusted OR 0.95,
95% CI 0.44–2.02).
Conclusions: Ultrasound effusion and synovial hypertrophy are associated with KP, but only effusion predicts KP
worsening. However, the association/prediction is not independent from ROA. Power Doppler signal is uncommon in
people with KP. Further study is needed to understand whether synovitis is directly involved in different types of KP.
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Background
Knee pain (KP) affects one in four people aged over
55 years, of whom 10% have mild-to moderate disability
[1]. KP is the main symptom of knee osteoarthritis (OA),
and the prevalence of OA continues to rise because of
increasing longevity and obesity, causing a significant
socio-economic burden [2, 3]. Individuals with KP but
normal radiographs are more likely to develop radio-
graphic OA (ROA) later, suggesting that KP can be a
symptom prior to the observable structure damage of
OA, not necessarily a consequence of structural alter-
ation sufficient to show on an X-ray image [4, 5]. The
classification criteria for OA probably exclude people
with early or structurally mild disease, which might also
contribute to KP in the community [1].
An important role for synovial pathology, specifically
synovitis, in the initiation and progression of knee OA
has been emphasised recently [6–9]. Ultrasonography
(US) is a commonly used imaging modality to detect
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soft-tissue changes in the knee [10]. It is relatively inex-
pensive, involves a short examination time, and correlates
in people with knee OA with histological findings [11, 12]
and magnetic resonance imaging (MRI) [13, 14]. With the
increasing focus on precision medicine, synovial pathology
has been proposed as a target for intervention and as a
biomarker for people who require anti-inflammatory ther-
apy for OA [15]. Therefore, it is important to know
whether US-detected synovial changes (USSCs) associate
with KP and predict changes in symptoms over time in
people who might benefit from targeted treatments [16].
However, evidence for this association in established OA
is conflicting [17–19]. Moreover, previous studies have re-
ported that radiographic structural changes, a strong risk
factor for KP [20, 21], also associate with USSCs [22].
Therefore, in order to explore the relationships between
KP and synovial changes it is important to account for
ROA and other peripheral risk factors such as muscle
strength. While muscle weakness associates with knee OA
[23], this association is independent of ROA severity
[24, 25]. Also, USSCs may differ in early and advanced
OA [26, 27], and the lack of studies in people recruited
from the community [28] may influence the generalis-
ability of previous results [29]. Furthermore, whether
USSCs predict changes in KP has not been examined [30].
The current study aimed to examine whether community-
derived people with early or established KP are more likely
to have USSCs, specifically effusion, synovial hypertrophy
and Power Doppler (PD) signal, compared to controls
without KP and to explore whether USSCs predict/
associate with subsequent KP worsening.
Methods
This study was approved by the Nottingham University
Hospitals NHS Trust and Nottingham Research Ethics
Committee 1 (Ref 14/EM/0015) and was registered on
ClinicalTrials.gov (NCT02098070) [31].
Study design and participant selection
Participants for this case–control study were selected
from the Knee Pain and Related Health in the
Community (KPIC) Study, an ongoing prospective cohort
study that included 9506 men and women aged ≥ 40 years
at baseline. A second questionnaire was posted 1 year later
to the 6716 participants who indicated willingness to re-
ceive a further questionnaire and who were alive.
Participants were selected according to current KP sta-
tus irrespective of subsequent radiographic findings.
“Early KP” was defined as pain commencing within the
past 3 years regardless of pain severity. “Established KP”
was moderate to severe KP of more than 3 years in dur-
ation. KP-free controls reported “no KP” in the past
5 years. Exclusions were: known terminal illness; severe
psychiatric illness or dementia; knee arthroplasty; major
prior knee/lower limb injury; or current pregnancy.
Selection for the early KP group was from all partici-
pants who met the inclusion criteria and agreed to par-
ticipate in clinical assessments. Participants for the
established KP and no KP groups were frequency
matched to early KP participants by age and gender.
Random selection was undertaken if more than one par-
ticipant was eligible for matching. In addition, all partici-
pants who reported incident KP at 1 year and met the
inclusion criteria were invited for assessment and in-
cluded in the early KP group.
Age, gender, height, pain status and use of prescribed
and/or over-the-counter analgesics (e.g. paracetamol,
NSAIDs and COX-2 selective inhibitors, opioids) were
self-reported in the postal questionnaire. At baseline all
participants had US, radiographic and muscle strength
assessments.
Pain assessment
KP was defined as pain in or around a knee on most
days for at least a month [32, 33]. A 0–10 numerical rat-
ing scale (NRS) was used to assess pain intensity in the
past month.
A patient global assessment (PGA) of KP change at
year 1 was defined by response to the question: “Since it
has started, do you think the severity of your knee pain
has overall … greatly improved/slightly improved/
remained the same/worsened”.
The index knee was the only or most painful knee. For
equal bilateral KP or no KP participants, the index knee
was selected randomly. Data on USSCs, ROA and
muscle strength were presented for index knees only.
Ultrasound assessment
US examination was performed by two assessors (MH,
AS) using the Toshiba Aplio SSA-770A machine with a
multi-frequency (7–12 MHz) linear array transducer.
The same equipment and software were used during the
whole study.
The assessment was performed with knee flexion of
approximately 20–30° and included the supra-patellar
recess and medial and lateral tibio-femoral spaces.
USSCs were defined using OMERACT-7 definitions
(Additional file 1) [34]. The depth of synovial thickness
(hypertrophy) and effusion were measured on a continu-
ous scale at their maximal diameter in millimetres using
the longitudinal axis. Absolute values were dichotomised
as absent (< 4 mm) or present (≥ 4 mm) according to
EULAR recommendations [35]. PD assessment was fo-
cused on areas of synovial hypertrophy and recorded as
absent or present. Only one value per joint was recorded
for each US feature (maximum value across three areas
scanned). It has been reported previously that overall
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agreement between synovial hypertrophy detected in
these three areas of the knee and synovitis detected
using arthroscopy (“gold standard”) was 97% with a non-
significant difference in sensitivity between the three
compartments [36].
Radiographic OA assessment
Bilateral weight-bearing semi-flexed posterior–anterior
tibio-femoral views using a Rosenberg template and 30°
flexion skyline patello-femoral views were undertaken
using standardised protocols. The Nottingham logically
derived line drawing atlas (LDLDA) [37, 38] was used to
score joint space narrowing (JSN) in medial and lateral
tibio-femoral and medial and lateral patello-femoral ar-
ticulations (each scored –1 to 5) and osteophytes (at
eight sites in the three compartments, each scored 0–5).
The scores for all three compartments, ignoring –1
values for JSN (i.e. joint space widening), were sum-
mated as a global score for each knee. Presence of ROA
was defined as definite JSN (grade 2) plus definite osteo-
phyte (grade 2) in any compartment (tibio-femoral or
patello-femoral).
Muscle strength assessment
Maximal isometric strength of quadriceps and hip ab-
ductor muscles was tested using a Nicholas Manual
Muscle Tester (MMT) (Lafayette Instruments) three
times on each leg and then the mean values were calcu-
lated for each side [39]. Normal tertiles of the quadri-
ceps and hip abductor strength were calculated from the
pain-free controls separately for men and women.
All assessments were independent, standardised and
blinded to participants’ characteristics including pain sta-
tus. USSCs, radiographic score and muscle strength in
index knees only were used for analysis.
Statistical analysis
Sample size
Baseline cross-sectional study An unbalanced (2:1:1
for “early KP”, “established KP”, “no KP”) one-way
ANOVA design was applied to ensure sufficient early KP
cases for the cohort study. The effect sizes reported by
Hall et al. [22] were used to calculate the sample size
(i.e. mean (SD) was 1.0 (1.9), 6.7 (3.3) and 0.7 (1.5) for
synovial hypertrophy in the three groups respectively).
Considering 90% power with 5% type I error, 80
participants were required for the primary analysis to
detect the minimum difference between the three groups
(40:20:20).
One-year follow-up study For the risk prediction
model, the sample size was calculated based on the lo-
gistic model with one predictor adjusted with three co-
variates (e.g. age, gender and BMI) assuming that there
is a correlation between covariates (r = 0.3). The
study was powered for an odds ratio (OR) as small
as 1.7 for synovial hypertrophy assuming that the
probability of worsening of KP is 14%,[28] (Ingham
SL, Zhang W, Doherty M: Natural history of knee
pain in the Nottingham community: health states and
transition probabilities in a 10 year retrospective co-
hort study. Unpublished manuscript, available on re-
quest). With 80% power and less than 5% type I
errors, 211 participants are required.
Primary analysis
Baseline cross-sectional study The association between
US features and KP was estimated using the OR and
95% confidence interval (CI). Multi-nominal logistic re-
gression was used to estimate ORs between the early,
established and no KP groups with the no KP group as
reference. The OR was adjusted for age, gender, BMI,
global X-ray score and quadriceps strength.
One-year follow-up study Potential baseline predictors
for KP worsening as defined by PGA were examined
using multivariate logistic regression analysis with ad-
justment for age, gender and BMI. Sensitivity analysis
was undertaken using an alternative definition of KP
worsening, defined by any increase in KP from baseline
on a NRS.
Other analyses
The cross-sectional association of USSCs with radio-
graphic severity was examined using a two-level general-
ised linear mixed model to adjust for cluster effects (i.e.
the difference between the three groups).
Reliability
The unweighted kappa statistic was used for dichotom-
ous data and concordance correlation for continuous
data [40, 41]. For the inter-observer reliability test, two
assessors (MH, AS) blindly, independently and consecu-
tively carried out the grey-scale and PD US examination
on the same day (16 individuals, 32 knees). Intra-
observer reliability (AS) was examined by scanning four
volunteers (eight knees) on two separate days within
a 7-day period. Inter-observer and intra-observer agree-
ment for radiographic scoring (AS, GSF) was examined
using images from 21 participants with different radio-
graphic severity (40 knees). Muscle strength reliability
testing was performed on 10 volunteers.
All statistical analyses were undertaken using SAS soft-
ware v9.4 licensed to the University of Nottingham.




At baseline 495 participants were recruited, of whom
298 had early KP, 103 established KP and 94 no KP. Of
those with early KP, 219 were recruited at baseline and
79 were incident cases identified during follow-up. Age
and gender were distributed equally among the three
groups. However, a graded increase from no KP to early
KP and then to established KP groups was observed for
BMI, pain severity, ROA, low quadriceps and hip ab-
ductor strength, and use of analgesics (Table 1).
Reliability
The level of inter-observer agreement was moderate
for effusion and substantial for synovial hypertrophy
(κ = 0.44 and 0.61, respectively). Intra-observer agree-
ment for effusion was moderate (κ = 0.50). There were
insufficient data to calculate kappa statistics for syn-
ovial hypertrophy (mean difference between measure-
ments 0.3 mm (SD 0.7)) and PD signal. Inter-observer
and intra-observer agreement on radiographic scoring
was substantial (all κ ≥ 0.78). Both inter-rater and
intra-rater reliability in muscle strength testing ranged
from adequate to excellent (0.64–0.94).
Ultrasound synovial features and KP
Effusion ≥ 4 mm was associated with KP, but this association
diminished after adjustment for age, gender, BMI, ROA
severity and quadriceps strength (Table 2). Synovial hyper-
trophy also associated with KP and this association
remained statistically significant after adjustment for age,
gender, BMI and radiographic severity. Adjusted ORs (95%
CIs) were 3.17 (1.17-8.53) for early KP and 4.97 (1.66-14.86)
for established KP. There was a strong association between
ROA and KP. ORs adjusted for age, gender and BMI were
4.37 (95% CI 1.89–10.13) and 11.82 (95% CI 4.71–29.66) for
early and established KP respectively. There were no interac-
tions between effusion/hypertrophy and radiographic sever-
ity (all p > 0.05, data not presented). Additional adjustment
for low quadriceps strength and analgesic use did not
change the strength of association (Additional file 2).
One year follow-up study
After 1 year, 181 (83%) participants with early KP and 74
(76%) participants with established KP completed the
follow-up questionnaire. There was no difference be-
tween those who returned the questionnaire and the en-
tire population (Additional file 3). After 1 year, 18% of
people with early KP reported that their pain had wors-
ened (n = 32 out of 181) and 42% of people with estab-
lished KP reported worsening of pain (n = 31 out of 74).
After adjustment for age, gender and BMI, effusion
(aOR 1.95, 95% CI 1.05–3.64) and ROA (aOR 4.73 95% CI
2.46 to 9.10) predicted worsening of KP (Table 3). How-
ever, the association between effusion and worsening of
KP adjustment for analgesic use did not change the
strength of association (data not presented).
Table 1 Characteristics of the study population
No knee pain Early knee pain Established knee pain p value
N 94 298 103
Age (years), mean (SD) 60.98 (9.81) 61.42 (9.66) 59.53 (10.04) 0.2992*
Women, n (%) 58 (61.70) 179 (60.07) 63 (61.17) 0.9509**
BMI (kg/m2), mean (SD) 26.78 (4.49) 28.85 (5.70) 31.96 (6.49) < 0.0001*
Pain severity (NRS 0–10)a, mean (SD) 4.55 (2.52) 7.40 (2.14) < 0.0001†
Global X-ray score (mm, 0–60), mean (SD) 2.24 (3.08) 5.72 (7.00) 11.28 (9.26) < 0.0001*
Radiographic OA, n (%) 7 (7.45) 80 (26.85) 49 (47.57) < 0.0001**
Muscle strengthb, n (%)
Quadriceps strength (kg, lowest tertile) 33 (35.11) 99 (33.22) 65 (63.11) < 0.0001**
Hip abductor strength (kg, lowest tertile) 33 (35.11) 119 (39.93) 68 (66.02) < 0.0001**
Use of analgesics, n (%)
Prescribed NSAIDs 3 (3.19) 19 (6.38) 15 (14.56) 0.0018
Opioids 3 (3.19) 44 (14.77) 22 (21.36) 0.0005
Over-the-counter NSAIDs 12 (12.77) 68 (22.82) 32 (31.07) 0.0021
Groups matched by age and gender. p values adjusted for multiple testing using the bootstrap method
SD standard deviation, NRS numerical rating scale, BMI body mass index, OA osteoarthritis, NSAID non-steroidal anti-inflammatory drug
†t test
*Test for linear trend
**Cochran–Armitage test for trend
aAverage pain severity in the past month
bLowest tertile values for muscle strength tests: quadriceps strength < 17.6 kg for men and < 10.7 kg for women; hip abductor strength < 12.8 kg
and < 8.2 kg, respectively
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The sensitivity analysis using any increase from base-
line in NRS for KP also showed that no US feature pre-
dicted increased KP (Additional file 4).
Other results
Ultrasound features and radiographic changes
At baseline, both effusion and synovial hypertrophy
showed dose–response relationships with global ROA
scores (Fig. 1). After adjusting for all other confounding
factors, the regression coefficients were 0.21 (95% CI
0.17–0.25) for effusion and 0.17 (95% CI 0.13–0.20) for
synovial hypertrophy (both p < 0.0001).
Discussion
To our knowledge, this is the first community-based
study to investigate USSCs and their association with
KP, adjusted for radiographic severity. The main findings
are: USSCs associate with KP, and the association is con-
founded by ROA severity; and effusion and ROA at
baseline predict KP worsening at 1 year, but the predic-
tion becomes insignificant after adjusting for ROA.
The association between synovial changes and KP in
OA have been investigated previously. In our recent
meta-analysis [42], seven out of 10 studies reported a
positive association between KP and effusion and two
out of six studies reported an association with synovial
hypertrophy. However, most studies did not adjust for
ROA. Although the prevalence of US-detected synovial
pathology (effusion, hypertrophy, PD) showed wide vari-
ability between studies, the pooled prevalence of these
features was significantly higher in people with knee OA
than in people with KP (p < 0.05). This prompted the
current study to investigate the relationship between US
features of “synovitis”, ROA and KP.
Table 2 Ultrasound synovial features at baseline and associations with knee pain
No knee pain Early knee pain Established knee pain p for trend
Effusion
Mean ± SD (mm) 3.02 (2.10) 4.48 (3.64) 5.89 (3.48) < 0.0001
≥ 4 mm, n (%) 23 (24.47) 136 (45.64) 64 (62.14) < 0.0001
≥ 4 mm, OR (95% CI) 1 2.64 (1.57–4.45) 5.07 (2.74–9.38)
≥ 4 mm, aOR (95% CI) 1 1.90 (1.07–3.39) 1.92 (0.92–4.00)
Synovial hypertrophy
Mean ± SD (mm) 0.65 (1.56) 2.01 (2.66) 3.57 (3.49) < 0.0001
≥ 4 mm, n (%) 5 (5.32) 69 (23.15) 44 (42.72) < 0.0001
≥ 4 mm, OR (95% CI) 1 5.43 (2.12–13.92) 13.27 (4.97–35.43)
≥ 4 mm, aOR (95% CI) 1 3.17 (1.17–8.53) 4.97 (1.66–14.86)
Power Doppler signals, n (%) 0 10 (3.36) 2 (1.94) 0.4252
aOR odds ratios adjusted for age, gender, BMI, quadriceps strength and radiographic osteoarthritis scores, CI confidence interval, OR odds ratio,
SD standard deviation
Table 3 Association between baseline risk factors and worsening of knee pain
Descriptive OR (95% CI)
Stable/improved Worsened Crude Age, gender, BMI-adjusted
N 192 63
Effusion
Mean (SD) (mm) 4.24 (3.44) 6.20 (4.09) 1.15 (1.06–1.24) 1.11 (1.02–1.20)
Effusion ≥ 4 mm, n (%) 79 (41.58) 40 (63.49) 2.44 (1.36–4.40) 1.95 (1.05–3.64)
Synovial hypertrophy
Mean (SD) (mm) 2.06 (2.89) 3.35 (3.35) 1.14 (1.04–1.24) 1.09 (0.99–1.20)
Thickness ≥ 4 mm, n (%) 45 (23.68) 24 (38.10) 1.98 (1.08–3.64) 1.40 (0.72–2.74)
Power Doppler signal, n (%) 8 (4.17) 1 (1.59) 0.37 (0.05–3.03) 0.47 (0.06–4.02)
Global radiographic score (0–-60), mean (SD) 5.81 (7.19) 13.58 (9.40) 1.11 (1.07–1.15) 1.10 (1.06–1.14)
Radiographic OA, n (%) 44 (23.16) 39 (62.90) 5.63 (3.04–10.41) 4.73 (2.46–9.10)
Quadriceps strength (kg, lowest tertile) 66 (34.74) 34 (53.97) 2.20 (1.24–3.93) 1.89 (1.04–3.46)
Significant associations are highlighted in bold
BMI body mass index, CI confidence interval, OA osteoarthritis, OR odds ratio, SD standard deviation
Sarmanova et al. Arthritis Research & Therapy  (2017) 19:281 Page 5 of 9
Our findings suggest that the association between
USSCs (“synovitis”) and KP may be confounded by
radiographic structural changes of OA. This is supported
by: the strong dose–response association between ROA
and synovial hypertrophy; the diminishing association
between KP and effusion after adjustment for ROA; and
the lack of prediction of USSCs for pain worsening in
contrast to the prediction of baseline ROA change for
pain worsening over 1 year. This suggests that
“synovitis” detected by US is not the main cause of KP
but a consequence of the overall pathology of OA that
involves all joint tissues. This has been confirmed by the
graded ORs from no KP, early KP and established KP
(Table 2). Our conclusion is that both US “synovitis” and
ROA are risk factors for KP and strongly relate to each
other. The positive association between synovial changes
and structural severity accords with the MRI findings
[43, 44]. Further studies that specifically examine the re-
lationship between synovial change and change in other
joint tissues are warranted.
In our study we found that presence of ROA is a prog-
nostic factor that predicts worsening of pain over 1 year.
The association between OA structural severity and KP
has been confirmed in a number of cross-sectional stud-
ies [20] whereas evidence for ROA as a predictor of KP
progression remained controversial [45].
Recently, there has been considerable interest in in-
flammation in OA and the possibility that “synovitis” is a
marker for an inflammatory phenotype of symptomatic
OA [6, 7]. However, in contrast to rheumatoid arthritis
(RA) and other arthropathies that are driven by inflam-
mation, the intensity of inflammation in OA is only
modest. Early-morning and inactivity stiffness are rela-
tively short in OA [46] and large effusions are atypical
and suggest co-existing inflammatory conditions such as
crystal synovitis [47–49]. Furthermore, although synovial
hyperplasia and effusion may occur in OA, synovial
hyperplasia is more focal than generalised, effusions have
relatively low cell counts with a preponderance of mono-
nuclear cells, and marginal cortical erosions do not
occur [50, 51]. This contrasts with RA where high cell
counts (causing turbidity) with a predominance of neu-
trophils and development of marginal cortical erosions
are characteristic. It is possible that effusion in knee OA
in part is non-inflammatory, arising from attrition of
lymphatics rather than fluid overproduction due to in-
flammation [52]. Generalised synovial hypertrophy and
strongly positive PD signal are US markers of inflamma-
tion in RA [53, 54], the PD signal indicating marked
hypervascularity. Although we found a positive associ-
ation between synovial hypertrophy and KP, the preva-
lence of the PD signal was very low in both KP groups.
Our data align with the perspective of OA as an inherent
repair process in which all tissues that comprise the syn-
ovial joint, including the synovium and capsule, respond
to diverse insults (including biomechanical factors) by
producing new tissue [50].
There are several caveats to this study. Firstly, it was
designed to primarily determine the association between
USSCs and KP, so associations with radiographic fea-
tures should be interpreted with caution. It is possible
that the associations between US and ROA with KP
might result from other associated factors. Secondly,
pain was re-assessed at just two time points and further
Fig. 1 Mean effusion (left) and mean synovial hypertrophy (right) for each group. Note: For global X-ray score (horizontal axis), the scale was categorised
as < 5, 5–9.99, 10–14.99 and > 15. Vertical error bars indicate standard error of the mean
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longer-term follow-ups are warranted. Thirdly, currently
there is no accepted standardised protocol for US assess-
ment. Our study included assessment of three areas
(supra-patellar pouch, medial and lateral aspects of the
knee) with the maximum value of effusion/hypertrophy
recorded per knee. Karim et al. [36] reported previously
that these three areas have similar sensitivity for detect-
ing of synovitis compared with synovitis detected using
arthroscopy (“gold standard”). However, a more detailed
protocol with separate scoring per area or using a multi-
compartmental summated score might reveal a different
association with KP. Fourthly, US and radiographs can-
not examine all joint changes in OA (e.g. bone marrow
lesions) and use of MRI, although expensive, would have
allowed more detailed and comprehensive assessment of
joint abnormalities. Lastly, the reliability of US assess-
ment is an important issue to consider. The level of
agreement between observers was not perfect but was at
least moderate and in line with an OMERACT reliability
exercise [55]. In that study the agreement between 11
experienced sonographers was fair for both effusion and
synovial hypertrophy (mean κ = 0.38 and 0.29, respect-
ively) and the intra-rater agreement was moderate for
both US features (mean κ = 0.56 and 0.49, respectively)
[55]. Unfortunately, PD signals were uncommon in the
study population (0% in no KP, 3% in early KP and 2% in
established KP), which limited the value of this measure.
Conclusions
In summary, USSCs (synovitis) are associated with KP
and the association is confounded by structural OA. Ef-
fusion but not synovial hypertrophy at baseline predicts
KP worsening at 1 year but the prediction is not inde-
pendent of ROA. USSCs are related to radiographic se-
verity of OA but the causal relationship between the two
has yet to be established.
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